GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Dbp | rn6_v1_chr1_+_101688297_101688297 | -0.04 | 4.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_-_39476384 Show fit | 53.85 |
ENSRNOT00000092968
|
glycoprotein m6a |
|
chr9_-_28732919 Show fit | 51.21 |
ENSRNOT00000083915
|
regulating synaptic membrane exocytosis 1 |
|
chr16_-_39476025 Show fit | 48.88 |
ENSRNOT00000014312
|
glycoprotein m6a |
|
chr6_+_48452369 Show fit | 43.02 |
ENSRNOT00000044310
|
myelin transcription factor 1-like |
|
chr11_+_42259761 Show fit | 42.47 |
ENSRNOT00000047310
|
Eph receptor A6 |
|
chr15_-_77736892 Show fit | 37.91 |
ENSRNOT00000057924
|
protocadherin 9 |
|
chr2_+_66940057 Show fit | 33.17 |
ENSRNOT00000043050
|
cadherin 9 |
|
chr2_-_89310946 Show fit | 32.70 |
ENSRNOT00000015195
|
RALY RNA binding protein-like |
|
chr2_+_54191538 Show fit | 31.79 |
ENSRNOT00000019524
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
|
chr16_-_28716885 Show fit | 31.73 |
ENSRNOT00000059750
|
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 102.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
1.3 | 59.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.4 | 53.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
17.1 | 51.2 | GO:0031632 | positive regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031632) |
1.3 | 34.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
4.0 | 31.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
6.1 | 30.6 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
5.1 | 30.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 30.1 | GO:1990138 | neuron projection extension(GO:1990138) |
1.5 | 28.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 129.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 120.3 | GO:0045202 | synapse(GO:0045202) |
0.3 | 81.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 56.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
6.4 | 51.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
1.0 | 45.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 34.2 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 27.5 | GO:0043235 | receptor complex(GO:0043235) |
1.1 | 25.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.3 | 24.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 90.5 | GO:0005262 | calcium channel activity(GO:0005262) |
3.6 | 71.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 52.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
4.3 | 34.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 34.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 31.8 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
2.6 | 31.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
2.4 | 30.8 | GO:0070097 | alpha-catenin binding(GO:0045294) delta-catenin binding(GO:0070097) |
1.4 | 30.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 27.4 | GO:0042802 | identical protein binding(GO:0042802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 88.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.6 | 30.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 26.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 25.2 | PID CDC42 PATHWAY | CDC42 signaling events |
1.2 | 20.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 19.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 16.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 14.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 13.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 11.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 67.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.6 | 44.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.4 | 38.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 30.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.1 | 27.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.5 | 25.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.6 | 23.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.3 | 22.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.5 | 15.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.1 | 13.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |